Ana Sofia Ferreira
Advertisement
Articles by Ana Sofia Ferreira
Advertisement
Latest Updated Articles
![TPS 24 Phase Ib Dose-Finding Study of [177Lu]Lu-NeoB + Ribociclib + Fulvestrant in Patients With ER+/HER2− Advanced Breast Cancer With GRPR Expression With Early Relapse FromAdjuvant Endocrine Therapy or Progression on ET + CDK4/6i for ABC](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/bb58c5f3c3692dc35c19320bb63c3df864f9b79b-1500x722.png?w=300&fit=crop&auto=format)
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC
2
Trastuzumab Deruxtecan Regimen Accepted for Review in HER2+ Breast Cancer
3
Uncovering Subsequent Research Considerations for Tarlatamab in ES-SCLC
4
FDA Grants Fast Track Designation to Novel PIK3α Inhibitor in Breast Cancer
5
